Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-794-5446- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Duke University HospitalResidency, Internal Medicine, 2008 - 2011
- University of Tennessee Health Science Center College of MedicineClass of 2008
Certifications & Licensure
- FL State Medical License 2021 - Present
- OK State Medical License 2020 - 2025
- WA State Medical License 2023 - 2025
- AL State Medical License 2023 - 2024
- TN State Medical License 2023 - 2024
- GA State Medical License 2023 - 2024
- TX State Medical License 2012 - 2024
- Join now to see all
Clinical Trials
- A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 Start of enrollment: 2015 Jul 16
- M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability Start of enrollment: 2018 Mar 07
- Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer Start of enrollment: 2019 Jun 14
Publications & Presentations
PubMed
- Institution-Wide Retreats Foster Organizational Learning and Action at a Comprehensive Cancer Center.Benjamin R Schrank, John A Fuller, Colleen M Gallagher, Van K Morris, Emma B Holliday, Kelly Merriman, Lynne Nguyen, Lou Weaver, Kelly Nelson, Elizabeth Chiao, Albert ...> ;Journal of Cancer Education. 2024 Mar 12
- Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling.Wang, X., Dasari, A., Shen, J., Drusbosky, L., Johnson, B., Morris, V., Raghav, K., Lee, M., Huey, R., Parseghian, C., Willis, J., Wolff, R., Overman, M., Kopetz, S.> ;Cancers. 2024 Feb 9
- Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy.Jordan McDonald, Michael K Rooney, Prajnan Das, Ethan B Ludmir, Bruce D Minsky, Craig Messick, George J Chang, Van K Morris, Emma B Holliday, Damron, E., Ethan P Damron> ;Clinical Colorectal Cancer. 2024 Mar 1
- Join now to see all
Journal Articles
- Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-ChallengeB Kee, N Garg, M J Overman, V K Morris, B Johnson, J Wu, J H Strickler, S Kopetz, X Liu, D S Hong, Annals of Oncology
Lectures
- NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- Are We Moving the Needle in Advanced Colorectal and Anal Cancers?ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Press Mentions
- Timely Surveillance with Chest Imaging May Benefit Colorectal Cancer PatientsOctober 16th, 2022
- MD Anderson Receives over $31 Million in CPRIT FundingFebruary 16th, 2022
- February eGuideFebruary 2nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: